Viewing Study NCT05929456


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2025-12-31 @ 2:57 PM
Study NCT ID: NCT05929456
Status: UNKNOWN
Last Update Posted: 2023-07-03
First Post: 2023-05-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)
Sponsor: University Medical Center Groningen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2023-05-05
Start Date Type: ACTUAL
Primary Completion Date: 2024-10-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-01-01
Completion Date Type: ESTIMATED
First Submit Date: 2023-05-25
First Submit QC Date: None
Study First Post Date: 2023-07-03
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-06-26
Last Update Post Date: 2023-07-03
Last Update Post Date Type: ACTUAL